Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy with mycobacteria.

Christoph Walker1, Elzbieta Sawicka, Graham A W Rook

  • 1Novartis Horsham Research Centre, Horsham, UK. christoph.walker@pharma.novartis.com

Current Opinion in Allergy and Clinical Immunology
|November 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution and the critical role of the microbiota in the reduced mental and physical health associated with low socioeconomic status (SES).

Neuroscience and biobehavioral reviews·2024
Same author

The old friends hypothesis: evolution, immunoregulation and essential microbial inputs.

Frontiers in allergy·2023
Same author

Well-posedness and stability analysis of an epidemic model with infection age and spatial diffusion.

Journal of mathematical biology·2023
Same author

Evolution, the Immune System, and the Health Consequences of Socioeconomic Inequality.

mSystems·2022
Same author

Comment on Parker <i>et al</i>. (<i>Evolution, Medicine and Public Health</i> 2021;9:120-30.).

Evolution, medicine, and public health·2021
Same author

Microbial exposures that establish immunoregulation are compatible with targeted hygiene.

The Journal of allergy and clinical immunology·2021

Recent studies on mycobacteria for asthma treatment show mixed results. While direct human efficacy is unproven, research suggests a link between mycobacteria, T regulatory cells, and protection against allergic diseases.

Area of Science:

  • Immunology
  • Microbiology
  • Respiratory Medicine

Background:

  • The role of mycobacterial exposure in allergic disease protection remains controversial.
  • Epidemiological studies on Mycobacterium tuberculosis and bacillus Calmette-Guérin have not resolved this debate.

Purpose of the Study:

  • To critically review recent advancements in using mycobacteria as a disease-modifying treatment for asthma.
  • To evaluate the potential of mycobacteria in asthma management.

Main Methods:

  • Review of recent epidemiological studies and clinical trials.
  • Analysis of findings from animal models investigating mycobacterial effects on immune responses.
  • Examination of molecular mechanisms, including T regulatory cell induction.

Related Experiment Videos

Main Results:

  • Mycobacterial treatment efficacy in human asthma has not been consistently demonstrated.
  • Studies on Mycobacterium vaccae in mice show induction of allergen-specific T regulatory cells, suppressing lung inflammation.
  • A deficiency in T regulatory cells may contribute to increased asthma prevalence, aligning with the hygiene hypothesis.

Conclusions:

  • Further research is necessary to elucidate the relationship between mycobacteria and atopic disorders.
  • Emerging molecular insights suggest potential therapeutic value for mycobacterial immunotherapy in asthma.